BG9719: Phase II

BGEN presented previously reported data from a 79-patient U.S. Phase II study in which BG9719 gave a statistically significant improvement in renal output and renal function versus placebo, as measured by creatinine clearance (see BioCentury, Feb. 22, 2000). Data were presented at the American College of Cardiology meeting in Orlando. ...